Filtriraj po Last updated date SelectPoznejePredFrom - To Date Končni datum This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate usePRIMECareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Leave this field blank Filter Rezultati (3839) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank European Medicines Agency's Scientific Coordination Board starts reflection on best cooperation between scientific committees 25 April 2012Press releaseMedicines Electronic application form pilot to be extended to initial veterinary applications 25 April 2012News eSubmission Gateway now live for all applications for human medicines to the European Medicines Agency 23 April 2012NewsMedicines European Medicines Agency maintains recommendation not to grant a marketing authorisation for Glybera 20 April 2012Press releaseHumanMedicines Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 16-19 April 2012 20 April 2012NewsHuman European Medicines Agency recommends authorisation of novel treatment for type-2 diabetes 20 April 2012Press releaseHumanMedicines European Medicines Agency gives new advice to better manage risk of adverse effects on the heart with Gilenya 20 April 2012Press releaseHumanMedicines Agnès Saint Raymond appointed to UN Commission on life-saving commodities for women and children 16 April 2012NewsPaediatrics Comments invited on the ICH E2C (R2) guideline on periodic benefit-risk evaluation report 16 April 2012NewsRegulatory and procedural guidance Towards a robust global framework for conduct and oversight of clinical trials 16 April 2012Press release 1 … 254 255 256 257 258 Page 258 of 384 259 260 261 262 … 384
European Medicines Agency's Scientific Coordination Board starts reflection on best cooperation between scientific committees 25 April 2012Press releaseMedicines
Electronic application form pilot to be extended to initial veterinary applications 25 April 2012News
eSubmission Gateway now live for all applications for human medicines to the European Medicines Agency 23 April 2012NewsMedicines
European Medicines Agency maintains recommendation not to grant a marketing authorisation for Glybera 20 April 2012Press releaseHumanMedicines
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 16-19 April 2012 20 April 2012NewsHuman
European Medicines Agency recommends authorisation of novel treatment for type-2 diabetes 20 April 2012Press releaseHumanMedicines
European Medicines Agency gives new advice to better manage risk of adverse effects on the heart with Gilenya 20 April 2012Press releaseHumanMedicines
Agnès Saint Raymond appointed to UN Commission on life-saving commodities for women and children 16 April 2012NewsPaediatrics
Comments invited on the ICH E2C (R2) guideline on periodic benefit-risk evaluation report 16 April 2012NewsRegulatory and procedural guidance
Towards a robust global framework for conduct and oversight of clinical trials 16 April 2012Press release